Literature DB >> 9852074

Werner syndrome protein. II. Characterization of the integral 3' --> 5' DNA exonuclease.

A S Kamath-Loeb1, J C Shen, L A Loeb, M Fry.   

Abstract

In addition to its DNA helicase activity, Werner syndrome protein (WRN) also possesses an exonuclease activity (Shen, J.-C., Gray, M. D., Kamath-Loeb, A. S., Fry, M., Oshima, J., and Loeb, L. A. (1998) J. Biol. Chem. 273, 34139-34144). Here we describe the properties of nearly homogeneous WRN exonuclease. WRN exonuclease hydrolyzes a recessed strand in a partial DNA duplex but does not significantly digest single-stranded DNA, blunt-ended duplex, or a protruding strand of a partial duplex. Although DNA is hydrolyzed in the absence of nucleoside triphosphates, nuclease activity is markedly stimulated by ATP, dATP, or CTP. WRN exonuclease digests DNA with a 3' --> 5' directionality to generate 5'-dNMP products, and DNA strands terminating with either a 3'-OH or 3'-PO4 group are hydrolyzed to similar extents. A recessed DNA strand with a single 3'-terminal mismatch is hydrolyzed more efficiently by WRN than one with a complementary nucleotide, but the enzyme fails to hydrolyze a DNA strand terminating with two mismatched bases. WRN exonuclease is distinguished from known mammalian DNA nucleases by its covalent association with a DNA helicase, preference for a recessed DNA strand, stimulation by ATP, ability to equally digest DNA with 3'-OH or 3'-PO4 termini, and its preferential digestion of DNA with a single 3'-terminal mismatch.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852074     DOI: 10.1074/jbc.273.51.34145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest.

Authors:  A Constantinou; M Tarsounas; J K Karow; R M Brosh; V A Bohr; I D Hickson; S C West
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

2.  A functional interaction of Ku with Werner exonuclease facilitates digestion of damaged DNA.

Authors:  D K Orren; A Machwe; P Karmakar; J Piotrowski; M P Cooper; V A Bohr
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Ku complex interacts with and stimulates the Werner protein.

Authors:  M P Cooper; A Machwe; D K Orren; R M Brosh; D Ramsden; V A Bohr
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

4.  Potent inhibition of werner and bloom helicases by DNA minor groove binding drugs.

Authors:  R M Brosh; J K Karow; E J White; N D Shaw; I D Hickson; V A Bohr
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

5.  Werner syndrome exonuclease catalyzes structure-dependent degradation of DNA.

Authors:  J C Shen; L A Loeb
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

6.  G4 DNA unwinding by BLM and Sgs1p: substrate specificity and substrate-specific inhibition.

Authors:  Michael D Huber; Damian C Lee; Nancy Maizels
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

7.  Processing of DNA for nonhomologous end-joining by cell-free extract.

Authors:  Joe Budman; Gilbert Chu
Journal:  EMBO J       Date:  2005-02-03       Impact factor: 11.598

Review 8.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

9.  WRN exonuclease activity is blocked by DNA termini harboring 3' obstructive groups.

Authors:  Jeanine A Harrigan; Jinshui Fan; Jamil Momand; Fred W Perrino; Vilhelm A Bohr; David M Wilson
Journal:  Mech Ageing Dev       Date:  2006-12-20       Impact factor: 5.432

10.  Functional deficit associated with a missense Werner syndrome mutation.

Authors:  Takashi Tadokoro; Ivana Rybanska-Spaeder; Tomasz Kulikowicz; Lale Dawut; Junko Oshima; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.